Structure Therapeutics Inc. Profile Avatar - Palmy Investing

Structure Therapeutics Inc.

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small…

Biotechnology
US, South San Francisco [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of GPCR's Analysis
CIK: 1888886 CUSIP: - ISIN: US86366E1064 LEI: - UEI: -
Secondary Listings
GPCR has no secondary listings inside our databases.